This study systematically reviews the molecular mechanisms by which NPs and TCM formulations inhibit VM formation across various tumor types, and summarizes multiple core intervention targets, including VE-cadherin, EphA2, MMPs, Twist1, HIF-1α, and PI3K/Akt. The gene discussed is EPHA2; the disease is neoplasm.